↓ Skip to main content

The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells

Overview of attention for article published in Arthritis Research & Therapy, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
patent
1 patent
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
192 Dimensions

Readers on

mendeley
130 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
Published in
Arthritis Research & Therapy, January 2011
DOI 10.1186/ar3400
Pubmed ID
Authors

Betty Y Chang, Min Huang, Michelle Francesco, Jun Chen, Jeremy Sokolove, Padmaja Magadala, William H Robinson, Joseph J Buggy

Abstract

The aim was to determine the effect of the Bruton tyrosine kinase (Btk)-selective inhibitor PCI-32765, currently in Phase I/II studies in lymphoma trials, in arthritis and immune-complex (IC) based animal models and describe the underlying cellular mechanisms.

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 126 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 41 32%
Student > Ph. D. Student 20 15%
Other 11 8%
Student > Master 9 7%
Student > Bachelor 7 5%
Other 18 14%
Unknown 24 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 33 25%
Medicine and Dentistry 27 21%
Chemistry 12 9%
Biochemistry, Genetics and Molecular Biology 10 8%
Immunology and Microbiology 6 5%
Other 14 11%
Unknown 28 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2021.
All research outputs
#2,175,316
of 21,963,432 outputs
Outputs from Arthritis Research & Therapy
#437
of 2,911 outputs
Outputs of similar age
#38,481
of 372,663 outputs
Outputs of similar age from Arthritis Research & Therapy
#4
of 26 outputs
Altmetric has tracked 21,963,432 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,911 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 372,663 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.